Dan Mendelson

by Jasmine Batchelor

January 8, 2019

Avalere Health

Dan Mendelson is Founder of Avalere Health.  Avalere is a vibrant community of innovative thinkers dedicated to solving the challenges of the healthcare system through data-driven advisory services and business intelligence products.  Dan founded the group in 2000, brought in ABS Capital as a minority investor in 2008, and grew the organically as CEO to span a community of 250 staff.  In 2015, Dan sold Avalere to Inovalon Holdings (INOV) and continued to operate the firm through the end of 2017.  He now serves as an advisor to the company.

From 1998 to 2000, Dan served as Associate Director for Health at the Office of Management and Budget in the Clinton White House.  He was responsible for the full healthcare portfolio including Medicare, Medicaid, NIH, CDC, and FDA. His work included development of the Medicare pharmaceutical benefit, Presidential initiatives in health information technology and medical error prevention, the electronic disease surveillance system, and federal policies in reimbursement and technology assessment.

Prior to joining OMB, Dan was Senior Vice President of The Lewin Group and Director of the Medical Technology Practice.  During his eight-year tenure at Lewin he had a range of responsibilities, including management of a transnational pharmaceutical and medical device consulting practice. Between 1994 and 1996 Dan was also closely involved in the operations of Value Rx, a pharmacy benefit management company (PBM). He also actively assisted both Value Health and Quintiles Transnational in due diligence on acquisitions.

Dan presently serves on the boards of Champions Oncology (CSBR) and Centrexion Therapeutics.  He is Executive in Residence at the Fuqua School of Business at Duke University and serves on the Advisory Board of the Duke Margolis Center.  Dan is a founding member of Guidon Partners, an investment management group.   Dan also serves on advisory boards for Faster Cures and the Alliance for Health Policy.  He previously served on the boards of Coventry Healthcare (sold to Aetna in 2013), PharMerica (PMC), and HMS holdings (HMSY).

Dan has published widely in peer-reviewed and professional journals on health information technology, the costs of disease, hospital costs and operations, physician payment, the economics of managed care, medical malpractice, and a range of other topics. He holds an undergraduate degree in economics and viola performance from Oberlin College (1986), and a Masters in Public Policy from the Kennedy School of Government at Harvard University (1990).

" "